|
IL10RB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.9685000000067E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.520200E-03 |
| Normal-vs-Stage2 |
3.978700E-03 |
| Normal-vs-Stage3 |
6.244100E-03 |
| Normal-vs-Stage4 |
4.018500E-02 |
| Stage1-vs-Stage2 |
4.472300E-02 |
| Stage1-vs-Stage3 |
3.869400E-01 |
| Stage1-vs-Stage4 |
7.018000E-02 |
| Stage2-vs-Stage3 |
3.158400E-01 |
| Stage2-vs-Stage4 |
8.344200E-01 |
| Stage3-vs-Stage4 |
2.904600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.774900E-04 |
| Normal-vs-AfricanAmerican |
1.021090E-04 |
| Normal-vs-Asian |
1.153190E-01 |
| Caucasian-vs-AfricanAmerican |
2.524400E-01 |
| Caucasian-vs-Asian |
1.095820E-01 |
| AfricanAmerican-vs-Asian |
2.296800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.01009999999991E-05 |
| Normal-vs-Female |
3.562300E-04 |
| Male-vs-Female |
5.809400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.200300E-02 |
| Normal-vs-Extreme_Weight |
2.578000E-04 |
| Normal-vs-Obese |
2.592400E-04 |
| Normal-vs-Extreme_Obese |
8.740400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.788240E-01 |
| Normal_Weight-vs-Obese |
1.427770E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.760820E-01 |
| Extreme_Weight-vs-Obese |
9.017800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.216100E-02 |
| Obese-vs-Extreme_Obese |
3.482400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.547900E-02 |
| Normal-vs-Age(41-60Yrs) |
9.77799999968276E-07 |
| Normal-vs-Age(61-80Yrs) |
5.022400E-03 |
| Normal-vs-Age(81-100Yrs) |
1.542830E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.991200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.450600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.626000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.736700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.089800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.583600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.51170000004275E-06 |
| Normal-VS-Type2 PRCC |
5.004300E-02 |
| Normal-VS-KIRP CIMP |
2.739100E-03 |
| Normal-VS-Unclassified PRCC |
1.715660E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.033700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.256500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.190200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.476860E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.221600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.082210E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.233680E-02 |
| Normal-vs-N1 |
1.857280E-03 |
| Normal-vs-N2 |
2.572400E-01 |
| N0-vs-N1 |
2.520800E-01 |
| N0-vs-N2 |
3.669000E-01 |
| N1-vs-N2 |
7.069600E-01 |
|
|
